The Dangers of Aspartame: New Study Links Artificial Sweetener to Heart Disease Risk
A recent study has revealed that the popular artificial sweetener aspartame could be posing a greater risk of heart disease to consumers due to a newly discovered chemical trigger on the lining of arteries.
Conducted by researchers from Sweden, China, and the US, the study involved administering doses of aspartame to mice over a period of 12 weeks, equivalent to the daily intake a human would consume in approximately three cans of diet soda.
Some of the mice were genetically modified to lack a key gene involved in metabolism, allowing insulin to have unregulated access to crucial receptors in their bodies.
Results showed that mice exposed to aspartame had higher levels of insulin, increased blood vessel inflammation, and more fatty plaques in their arteries compared to the control group, increasing the likelihood of heart attacks or strokes.
While these findings have yet to be replicated in humans, cardiovascular physiologist James Leiper from the British Heart Foundation emphasized the need for further research to determine the impact of artificial sweeteners on insulin levels and cardiovascular health.
The study also identified a signal molecule called CX3CL1 that became more active as insulin levels rose. Removing CX3CL1 receptors in the mice halted the accumulation of plaque in arteries, suggesting a potential target for future treatments to mitigate heart damage.
Vascular biologist Yihai Cao from the Karolinska Institute in Sweden explained that CX3CL1 remains attached to the inner lining of blood vessels, attracting immune cells and contributing to arterial damage.
The intense sweetness of aspartame, approximately 200 times sweeter than sugar, triggers excessive insulin production in the body, leading to adverse effects on vascular health and the development of atherosclerosis.
While artificial sweeteners are often perceived as healthier alternatives to sugar, previous studies have linked them to various health risks including cancer, anxiety, and cognitive issues.
Chemist Oliver Jones from RMIT University in Australia cautioned against overstating the risks associated with aspartame, emphasizing the importance of considering other factors such as diet and exercise in cardiovascular health.
Further research is needed to fully understand the mechanisms by which artificial sweeteners impact heart health and to validate these findings in human subjects.
The study, published in Cell Metabolism, underscores the importance of investigating the potential cardiovascular implications of artificial sweeteners for effective prevention and treatment strategies.
